Objective To describe demographic & clinical aspects of febrile seizures (FS) presenting to Teaching Hospital (TH) Kurunegala
Introduction
There are two published definitions of febrile seizures (FS). The International League Against Epilepsy (ILAE) defines a febrile seizure as "a seizure occurring in childhood after one month of age, associated with a febrile illness not caused by an infection of the central nervous system, without previous neonatal seizures or a previous unprovoked seizure, and not meeting criteria for other acute _________________________________________ 1 were included in the study. Data was collected using a pretested questionnaire administered to the parents or guardians of these children. Exclusion criteria included children less than 1 month of age, those with central nervous system (CNS) infections and those with symptomatic seizures (e.g. due to hypoglycaemia). Patients with developmental delay were not excluded.
A simple FS was defined as a generalized seizure with no focal seizure activity or focal manifestations during the postictal period, lasting less than 15 minutes and not recurring within the next 24 hours or during the same febrile illness.
A complex FS was defined as a seizure with features suggestive of focal activity at the onset, during or in the postictal period or a seizure lasting more than 15 minutes or a seizure that recurred within 24 hours or within the same febrile illness.
Results
Two thousand one hundred and seventeen children between the ages of one month and 5 years were admitted to TH Kurunegala from February to November 2005. One hundred and seventeen (5.5%) of these children had FS. Male to female ratio was 1.7:1 with a mean age at presentation of 17 months.
In 34% of patients the first seizure occurred under the age of one year and in 74%, the seizures occurred within the first 24 hours of onset of fever. Thirty four percent had complex FS. A family history of FS in a first degree relative was obtained in 43 (37%) patients. A family history of epilepsy was not present in any of the patients. Developmental delay, defined as a developmental score of less than 2 SD or 70% for age, was present in 12 (10%) patients. Two of these patients had global developmental delay (delay in 2 or more than 2 domains of development) 3 . Forty seven (40%) patients presented with recurrences during the study period.
Nine (8%) children were on long term anticonvulsant drugs viz. sodium valproate (4), phenobarbitone (3), clobazam (1) and carbamazepine (1) . Febrile status epilepticus, defined as seizure activity lasting for more than 30 minutes, or 2 or more seizures occurring during a period of 30 minutes without the patient regaining consciousness in between, was observed in 4 (3.4%) patients.
Discussion
The incidence of FS varies from 2-4% in Western Europe and USA, 5-10% in India, 8.8% in Japan and 14% in Guam 1 . However, the exact incidence of FS in Sri Lanka is not known. In my hospital based series 5.5% of children between the ages of one month and five years admitted to the paediatric unit had FS compared to 3% in the LRH series 2 . The incidence of complex FS in the study group was 34% compared with 25% in the LRH series 2 . However, it should be noted that children with developmental delay were excluded from the LRH series 2 .
In 34% of patients in my series the first seizure occurred under the age of one year compared with 39% in the LRH series 2 . A family history of FS in a first degree relative was present in 37% of patients in my study compared with 25% in the LRH survey 2 .
The recurrence risk of FS in this study was found to be significantly higher among patients who have had a 1 st degree relative with FS and this observation correlates well with the findings of other workers 1 .
Eight percent of children were on long term anticonvulsants drugs. Whilst sodium valproate and phenorbarbitone are effective in prevention of FS recurrences, both agents have known adverse effects and cannot be recommended for prevention of febrile seizures 4 . However, clobazam and carbamazepine have no place in prophylaxis of FS 4 .
Some of the children in this study may have had epileptic seizures precipitated by fever. However, the exact number of patients that went on to develop epilepsy in this series is not known as the study was conducted over a period of 10 months.
